Tirzepatide Improved Kidney Outcomes The SURPASS-4 clinical trial was part of phase 3 of SURPASS clinical trial program that tests the tirzepatide as monotherapy, an add-on to other treatments, and in comparison to other types 2 diabetes drugs, and weight loss agents in people with diabetes and obesity
Avoid lying down after you eat
Health coaches tracked CGM data trends, body weight fluctuations, blood pressure changes, and ketone levels via Keto Mojo meters to provide personalized recommendations and ensure safe metabolic adaptation
Practical considerations for getting started If you and your healthcare provider decide that GLP-1 microdosing is worth exploring for your autoimmune condition, here are the practical details that matter
The Mifflin-St Jeor equation often helps estimate resting metabolic rate
This treatment option that prevents heart disease and strokes is an important step forward in tackling the serious health consequences of obesity. Professor John Wilding, professor in the department of cardiovascular medicine at the University of Liverpool, said the approval is good news based on evidence from the trial